vs
Gossamer Bio, Inc.(GOSS)与NexPoint Real Estate Finance, Inc.(NREF)财务数据对比。点击上方公司名可切换其他公司
Gossamer Bio, Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.2倍($13.8M vs $11.1M),NexPoint Real Estate Finance, Inc.净利率更高(216.6% vs -342.3%,领先559.0%),Gossamer Bio, Inc.同比增速更快(47.1% vs -48.8%)
Gossamer Bio是一家临床阶段生物制药企业,专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法,推进多条自研候选药物管线进入不同临床阶段,主要面向北美及全球其他地区的医疗市场。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业,主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案,运营并管理抵押贷款及其他地产相关投资组合,为利益相关方提供经风险调整的稳定回报。
GOSS vs NREF — 直观对比
营收规模更大
GOSS
是对方的1.2倍
$11.1M
营收增速更快
GOSS
高出96.0%
-48.8%
净利率更高
NREF
高出559.0%
-342.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.8M | $11.1M |
| 净利润 | $-47.2M | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | -333.6% | — |
| 净利率 | -342.3% | 216.6% |
| 营收同比 | 47.1% | -48.8% |
| 净利润同比 | -43.0% | 58.7% |
| 每股收益(稀释后) | $-0.21 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GOSS
NREF
| Q4 25 | $13.8M | $11.1M | ||
| Q3 25 | $13.3M | $12.5M | ||
| Q2 25 | — | $12.1M | ||
| Q1 25 | — | $11.5M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | — | $12.5M | ||
| Q2 24 | $95.8M | $6.7M | ||
| Q1 24 | $0 | $-12.8M |
净利润
GOSS
NREF
| Q4 25 | $-47.2M | $24.0M | ||
| Q3 25 | $-48.2M | $50.9M | ||
| Q2 25 | — | $22.3M | ||
| Q1 25 | — | $26.0M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $23.3M | ||
| Q2 24 | $49.2M | $12.1M | ||
| Q1 24 | $-41.9M | $-14.6M |
营业利润率
GOSS
NREF
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — |
净利率
GOSS
NREF
| Q4 25 | -342.3% | 216.6% | ||
| Q3 25 | -362.7% | 407.0% | ||
| Q2 25 | — | 184.5% | ||
| Q1 25 | — | 225.6% | ||
| Q4 24 | — | 69.9% | ||
| Q3 24 | — | 186.4% | ||
| Q2 24 | 51.4% | 179.7% | ||
| Q1 24 | — | 114.3% |
每股收益(稀释后)
GOSS
NREF
| Q4 25 | $-0.21 | $0.47 | ||
| Q3 25 | $-0.21 | $1.14 | ||
| Q2 25 | — | $0.54 | ||
| Q1 25 | — | $0.70 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | $0.22 | $0.40 | ||
| Q1 24 | $-0.19 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $136.9M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $-122.8M | $388.0M |
| 总资产 | $172.2M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势,按日历期对齐
现金及短期投资
GOSS
NREF
| Q4 25 | $136.9M | $31.1M | ||
| Q3 25 | $180.2M | $17.9M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $19.2M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $34.7M | ||
| Q2 24 | $354.5M | $4.3M | ||
| Q1 24 | $244.4M | $13.5M |
总债务
GOSS
NREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益
GOSS
NREF
| Q4 25 | $-122.8M | $388.0M | ||
| Q3 25 | $-82.3M | $375.4M | ||
| Q2 25 | — | $348.2M | ||
| Q1 25 | — | $343.7M | ||
| Q4 24 | — | $336.5M | ||
| Q3 24 | — | $335.8M | ||
| Q2 24 | $81.5M | $327.5M | ||
| Q1 24 | $26.7M | $327.1M |
总资产
GOSS
NREF
| Q4 25 | $172.2M | $5.3B | ||
| Q3 25 | $208.8M | $5.3B | ||
| Q2 25 | — | $5.4B | ||
| Q1 25 | — | $5.4B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | — | $5.7B | ||
| Q2 24 | $373.4M | $6.6B | ||
| Q1 24 | $259.4M | $7.1B |
负债/权益比
GOSS
NREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-48.3M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
GOSS
NREF
| Q4 25 | $-48.3M | $-4.5M | ||
| Q3 25 | $-36.2M | $8.1M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $14.7M | ||
| Q2 24 | $116.3M | $-7.5M | ||
| Q1 24 | $-52.3M | $17.7M |
资本支出强度
GOSS
NREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
现金转化率
GOSS
NREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | 2.36× | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图